Break Up Big Medicine Act

The Break Up Big Medicine Act requires large healthcare companies that own multiple parts of the healthcare system (such as insurance, pharmacies, and physician practices) to divest certain businesses to eliminate conflicts of interest. It prohibits common ownership between entities like health insurers and physician practices, or drug wholesalers and medical providers, mandating divestiture within one year of enactment. Non-compliance would trigger penalties including monthly escrow of 10% of profits, and the bill allows government agencies and individuals to sue for violations. This directly affects the largest health insurance companies, pharmacy benefit managers, and drug distributors that have integrated operations across the healthcare sector.